Change From Baseline in Selected Hematology Parameters 2
A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas · Source last updated 2025-08-03
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Measure
MEAN
Unit
10^9 cells/L
Interval / dispersion
Standard Deviation
Time frame
baseline, months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36
What was measured
Change from baseline in selected hematology parameters such as leukocytes, lymphocytes, neutrophils, and platelets. Baseline value will be defined as the last value on the randomization date (+3 days) or before the date/time of randomization (date if date/time not collected).
Analysis population: All treated participants with a baseline value and a post-baseline value at the time point
Groups in this outcome
Standard of Care Arm
3 cycles of standard of care (SOC) salvage therapy (R-DHAP, R-ICE and R-GDP) per physician's choice. Participants responding to SOC are expected to undergo high dose chemotherapy (HDCT) and hematopoietic stem cell transplant (HSCT). If requested by the investigator, participants may be allowed to receive JCAR017 upon meeting progression, relapse, or suboptimal response. 1 cycle = 3 weeks
Liso-cel Arm
\[Lymphodepleting chemotherapy (LDC)\] Fludarabine IV (30 mg/m\^2/day for 3 days) and cyclophosphamide IV (300 mg/m\^2/day for 3 days) followed by JCAR017 IV infusion at a dose of 100 x 10\^6 JCAR017-positive viable transduced T cells (CAR+ T cells) on Day 29 (2 to 7 days after completion of LD chemotherapy)
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
73
Liso-cel Arm
84
Reported measurements
Month 1 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
73
Liso-cel Arm
84
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.815
6.9413
Not reported
Not reported
Not reported
Liso-cel Arm
-3.219
2.4688
Not reported
Not reported
Not reported
Month 2 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.870
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 3 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
41
Liso-cel Arm
72
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-3.445
5.8845
Not reported
Not reported
Not reported
Liso-cel Arm
-2.234
2.3520
Not reported
Not reported
Not reported
Month 4 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-1.180
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 6 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
30
Liso-cel Arm
62
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-1.699
1.9099
Not reported
Not reported
Not reported
Liso-cel Arm
-1.853
2.5876
Not reported
Not reported
Not reported
Month 9 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
22
Liso-cel Arm
60
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.710
3.0670
Not reported
Not reported
Not reported
Liso-cel Arm
-1.156
3.3604
Not reported
Not reported
Not reported
Month 12 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
18
Liso-cel Arm
59
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.427
1.4093
Not reported
Not reported
Not reported
Liso-cel Arm
-1.138
2.3772
Not reported
Not reported
Not reported
Month 18 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
19
Liso-cel Arm
52
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.598
1.6136
Not reported
Not reported
Not reported
Liso-cel Arm
-1.088
2.8028
Not reported
Not reported
Not reported
Month 24 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
45
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.694
3.0465
Not reported
Not reported
Not reported
Liso-cel Arm
-0.806
2.5709
Not reported
Not reported
Not reported
Month 36 leukocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
41
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.761
2.3637
Not reported
Not reported
Not reported
Liso-cel Arm
-0.970
3.0158
Not reported
Not reported
Not reported
Month 1 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
73
Liso-cel Arm
83
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.2824
0.43519
Not reported
Not reported
Not reported
Liso-cel Arm
-0.7380
0.43499
Not reported
Not reported
Not reported
Month 2 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.2100
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 3 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
19
Liso-cel Arm
71
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.4216
0.55872
Not reported
Not reported
Not reported
Liso-cel Arm
-0.1318
0.43385
Not reported
Not reported
Not reported
Month 4 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.1700
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 6 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
30
Liso-cel Arm
62
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.1343
0.38219
Not reported
Not reported
Not reported
Liso-cel Arm
-0.0845
0.48047
Not reported
Not reported
Not reported
Month 9 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
22
Liso-cel Arm
60
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.3264
0.66121
Not reported
Not reported
Not reported
Liso-cel Arm
-0.0442
0.39684
Not reported
Not reported
Not reported
Month 12 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
18
Liso-cel Arm
59
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.5089
0.71831
Not reported
Not reported
Not reported
Liso-cel Arm
0.0097
0.37252
Not reported
Not reported
Not reported
Month 18 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
19
Liso-cel Arm
52
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.6942
0.98993
Not reported
Not reported
Not reported
Liso-cel Arm
0.2283
0.55421
Not reported
Not reported
Not reported
Month 24 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
45
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
0.8688
1.12695
Not reported
Not reported
Not reported
Liso-cel Arm
0.3298
0.51386
Not reported
Not reported
Not reported
Month 36 lymphocytes
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
40
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
1.2253
1.20268
Not reported
Not reported
Not reported
Liso-cel Arm
0.3550
0.55387
Not reported
Not reported
Not reported
Month 1 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
73
Liso-cel Arm
83
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
1.368
6.5393
Not reported
Not reported
Not reported
Liso-cel Arm
-2.065
2.3479
Not reported
Not reported
Not reported
Month 2 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.590
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 3 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
19
Liso-cel Arm
71
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.621
6.8377
Not reported
Not reported
Not reported
Liso-cel Arm
-1.909
2.1727
Not reported
Not reported
Not reported
Month 4 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-1.160
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 6 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
30
Liso-cel Arm
62
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-1.648
1.7635
Not reported
Not reported
Not reported
Liso-cel Arm
-1.584
2.4539
Not reported
Not reported
Not reported
Month 9 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
22
Liso-cel Arm
60
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.879
2.9777
Not reported
Not reported
Not reported
Liso-cel Arm
-1.001
3.1318
Not reported
Not reported
Not reported
Month 12 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
18
Liso-cel Arm
59
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.822
1.5780
Not reported
Not reported
Not reported
Liso-cel Arm
-1.035
2.2898
Not reported
Not reported
Not reported
Month 18 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
19
Liso-cel Arm
52
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-1.167
1.3772
Not reported
Not reported
Not reported
Liso-cel Arm
-1.189
2.6342
Not reported
Not reported
Not reported
Month 24 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
45
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.124
2.5434
Not reported
Not reported
Not reported
Liso-cel Arm
-0.998
2.5506
Not reported
Not reported
Not reported
Month 36 neutrophils
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
40
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-0.404
1.8392
Not reported
Not reported
Not reported
Liso-cel Arm
-0.998
2.5222
Not reported
Not reported
Not reported
Month 1 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
72
Liso-cel Arm
78
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
13.9
140.94
Not reported
Not reported
Not reported
Liso-cel Arm
29.4
115.53
Not reported
Not reported
Not reported
Month 2 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
13.0
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 3 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
38
Liso-cel Arm
71
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-189.5
132.93
Not reported
Not reported
Not reported
Liso-cel Arm
-65.7
100.52
Not reported
Not reported
Not reported
Month 4 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
1
Liso-cel Arm
0
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-74.0
NA
Not reported
Not reported
insufficient number of participants to calculate standard deviation
Month 6 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
30
Liso-cel Arm
60
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-45.5
94.13
Not reported
Not reported
Not reported
Liso-cel Arm
-48.2
89.04
Not reported
Not reported
Not reported
Month 9 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
22
Liso-cel Arm
58
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-57.0
110.48
Not reported
Not reported
Not reported
Liso-cel Arm
-48.9
89.29
Not reported
Not reported
Not reported
Month 12 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
18
Liso-cel Arm
56
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-66.5
85.82
Not reported
Not reported
Not reported
Liso-cel Arm
-42.4
92.65
Not reported
Not reported
Not reported
Month 18 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
19
Liso-cel Arm
52
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-68.0
84.69
Not reported
Not reported
Not reported
Liso-cel Arm
-32.6
81.68
Not reported
Not reported
Not reported
Month 24 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
44
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-29.4
103.87
Not reported
Not reported
Not reported
Liso-cel Arm
-28.7
79.70
Not reported
Not reported
Not reported
Month 36 platelets
Analysis denominator · Participants
Group
Source count
Standard of Care Arm
17
Liso-cel Arm
40
Values in 10^9 cells/L · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Standard of Care Arm
-45.2
123.28
Not reported
Not reported
Not reported
Liso-cel Arm
-10.5
72.79
Not reported
Not reported
Not reported
Complete source fields
classes
categories
measurements
group Id
OG000
spread
6.9413
value
0.815
group Id
OG001
spread
2.4688
value
-3.219
denoms
counts
group Id
OG000
value
73
group Id
OG001
value
84
units
Participants
title
Month 1 leukocytes
categories
measurements
comment
insufficient number of participants to calculate standard deviation
group Id
OG000
spread
NA
value
-0.870
denoms
counts
group Id
OG000
value
1
group Id
OG001
value
0
units
Participants
title
Month 2 leukocytes
categories
measurements
group Id
OG000
spread
5.8845
value
-3.445
group Id
OG001
spread
2.3520
value
-2.234
denoms
counts
group Id
OG000
value
41
group Id
OG001
value
72
units
Participants
title
Month 3 leukocytes
categories
measurements
comment
insufficient number of participants to calculate standard deviation
group Id
OG000
spread
NA
value
-1.180
denoms
counts
group Id
OG000
value
1
group Id
OG001
value
0
units
Participants
title
Month 4 leukocytes
categories
measurements
group Id
OG000
spread
1.9099
value
-1.699
group Id
OG001
spread
2.5876
value
-1.853
denoms
counts
group Id
OG000
value
30
group Id
OG001
value
62
units
Participants
title
Month 6 leukocytes
categories
measurements
group Id
OG000
spread
3.0670
value
-0.710
group Id
OG001
spread
3.3604
value
-1.156
denoms
counts
group Id
OG000
value
22
group Id
OG001
value
60
units
Participants
title
Month 9 leukocytes
categories
measurements
group Id
OG000
spread
1.4093
value
-0.427
group Id
OG001
spread
2.3772
value
-1.138
denoms
counts
group Id
OG000
value
18
group Id
OG001
value
59
units
Participants
title
Month 12 leukocytes
categories
measurements
group Id
OG000
spread
1.6136
value
-0.598
group Id
OG001
spread
2.8028
value
-1.088
denoms
counts
group Id
OG000
value
19
group Id
OG001
value
52
units
Participants
title
Month 18 leukocytes
categories
measurements
group Id
OG000
spread
3.0465
value
0.694
group Id
OG001
spread
2.5709
value
-0.806
denoms
counts
group Id
OG000
value
17
group Id
OG001
value
45
units
Participants
title
Month 24 leukocytes
categories
measurements
group Id
OG000
spread
2.3637
value
0.761
group Id
OG001
spread
3.0158
value
-0.970
denoms
counts
group Id
OG000
value
17
group Id
OG001
value
41
units
Participants
title
Month 36 leukocytes
categories
measurements
group Id
OG000
spread
0.43519
value
-0.2824
group Id
OG001
spread
0.43499
value
-0.7380
denoms
counts
group Id
OG000
value
73
group Id
OG001
value
83
units
Participants
title
Month 1 lymphocytes
categories
measurements
comment
insufficient number of participants to calculate standard deviation
group Id
OG000
spread
NA
value
-0.2100
denoms
counts
group Id
OG000
value
1
group Id
OG001
value
0
units
Participants
title
Month 2 lymphocytes
denoms
counts
group Id
OG000
value
73
group Id
OG001
value
84
units
Participants
description
Change from baseline in selected hematology parameters such as leukocytes, lymphocytes, neutrophils, and platelets. Baseline value will be defined as the last value on the randomization date (+3 days) or before the date/time of randomization (date if date/time not collected).
dispersion Type
Standard Deviation
groups
description
3 cycles of standard of care (SOC) salvage therapy (R-DHAP, R-ICE and R-GDP) per physician's choice. Participants responding to SOC are expected to undergo high dose chemotherapy (HDCT) and hematopoietic stem cell transplant (HSCT). If requested by the investigator, participants may be allowed to receive JCAR017 upon meeting progression, relapse, or suboptimal response. 1 cycle = 3 weeks
id
OG000
title
Standard of Care Arm
description
\[Lymphodepleting chemotherapy (LDC)\] Fludarabine IV (30 mg/m\^2/day for 3 days) and cyclophosphamide IV (300 mg/m\^2/day for 3 days) followed by JCAR017 IV infusion at a dose of 100 x 10\^6 JCAR017-positive viable transduced T cells (CAR+ T cells) on Day 29 (2 to 7 days after completion of LD chemotherapy)
id
OG001
title
Liso-cel Arm
param Type
MEAN
population Description
All treated participants with a baseline value and a post-baseline value at the time point
reporting Status
POSTED
time Frame
baseline, months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36
title
Change From Baseline in Selected Hematology Parameters 2